期刊文献+

2000-2011年广州市城区甲状腺癌的发病趋势分析 被引量:15

Time trends of the incidence of thyroid cancer in urban Guangzhou, 2000 - 2011
原文传递
导出
摘要 目的分析2000-2011年广州市城区甲状腺癌的发病情况及变化趋势。方法利用广州市肿瘤登记处2000-2011年广州市城区甲状腺癌的发病和人口资料,共计2957例,覆盖人口45699522人年,其中男性649例,覆盖人口23391743人年,女性2308例,覆盖人口22307779人年,计算分析不同年度、年龄段的粗发病率、中国人口结构标化发病率(中标发病率)、世界人口构成标化发病率(世标发病率)和发病年度变化百分比(APC),分析各性别和年龄段发病率的变化趋势。结果2000-2011年广州市城区居民甲状腺癌发病共2957例,男女发病患者例数比为1:3.56,世标发病率从2000年的2.99/10万上升到2011年9.13/10万,增加了204.73%,APC为10.5%(P〈0.001);男性的世标发病率从2000年的1.32/10万上升到2011年的3.54/10万,增加了169.45%,APC为8.6%(P〈0.001);女性世标发病率从2000年的4.73/10万上升到2011年的14.87/10万,增加了214.64%,APC为10.9%(P〈0.001)。男性和女性甲状腺癌发病年龄有较大差别,女性45~59岁为发病高峰,为19.56/10万,男性发病率则随着年龄增长逐步增加,由15~19岁的0.74/10万增加到85岁以上组的9.48/10万。20~59岁年龄组男、女性APC分别为12.2%、13.4%,差异均有统计学意义(P〈0.001)。结论甲状腺癌发病呈逐年上升趋势,20~59岁年龄组人群是甲状腺癌防治的重点人群。 Objective To investigate the incidence and trends of thyroid cancer in urban areas of Guangzhou,2000- 2011. Methods Total of 2 957 new cases with a coverage population of 45 699 522 person-years diagnosed as thyroid cancer in 2000 -2011 in urban areas of Guangzhou were extracted from the population-based data base of Guangzhou cancer registry, among which 649 were males and 2 308 were females with a coverage population of 23 391 743 person-years and 22 307 779 person-years,respectively. The crude incidence, Chinese age-adjusted incidence rate and world age-adjusted incidence rate were calculated. Time trends of different gender and age groups Were examined using Joinpoint Regression Program. Results There were a total of 2 957 cases diagnosed as thyroid cancer during 2000 -2011 with a sex ratio of 1 : 3.56. World age adjusted incidence rates of thyroid cancer in urban areas of Guangzhou increased dramatically from 2. 99/100 000 in 2000 to 9. 13/100 000 in 201l with an increase rate of 204.73%. Annual percentage change (APC)was 10. 5% (P 〈 0. 001 ). The APC in world age adjusted incidence rates of thyroid cancer were 8.6% ( P 〈 0. 001 ) for male and 10. 9% ( P 〈 0. 001 ) for female, rcsuhing in a total increase of 169.45% (from 1.32/100 000 to 3.54/100 000) for male and 214. 64% for temale(from 4. 73/100 000 to 14. 87/100 000). The mean age of onset of thyroid cancer was significantly different between the males and females. The incidence rate of thyroid cancer in females aged 45 - 59 group (19. 56/100 000) reached the highest one. While in males, it was increasing gradually with the age, the incidence increased from 0.74/100 000 in aged 15 - 19 to 9.48/10 000 in aged of 85 years above. The APC was significant in 20 - 59 age groups in both males(12.2%) and females(13.4%) (P 〈 0.001).Conclusions The incidence rate of thyroid cancer increased rapidly in urban areas of Guangzhou. The prevention and treatment of thyroid cancer should be focused on 20 -59 age groups.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2015年第2期142-146,共5页 Chinese Journal of Preventive Medicine
关键词 甲状腺肿瘤 流行病学 发病率 横断面研究 Thyroid neoplasms Epidemiology Incidence Cross-sectional studies
作者简介 通信作者:吴娴波,Email:wxb70@126.com
  • 相关文献

参考文献17

二级参考文献106

共引文献527

同被引文献137

  • 1继发性骨质疏松症诊疗指南(讨论稿)[J].中华全科医师杂志,2006,5(8):459-460. 被引量:13
  • 2关海霞,单忠艳,米小轶,王恩华,滕卫平.普遍食盐碘化前后甲状腺癌发病变化的11年病理资料分析[J].中国医科大学学报,2006,35(3):284-285. 被引量:106
  • 3李春雨,崔小波,饶英生,孙鑫贵.北京市1997—2004年三次居民吸烟情况分析比较[J].中华流行病学杂志,2007,28(5):453-456. 被引量:5
  • 4Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg, 2014, 140(4): 317-322.
  • 5Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab, 2006, 91(1): 313-319.
  • 6Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab, 2006, 91(8): 2892-2899.
  • 7Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab, 2008, 93(10): 3943-3949.
  • 8Husain M, Alsever RN, Lock JP, et al. Failure of medullary carci- noma of the thyroid to respond to doxorubicin therapy. Horm Res, 1978, 9(1): 22-25.
  • 9Smallridge RC, Marlow LA, Copland JA. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer, 2009, 16(1): 17-44.
  • 10Smith NR, Baker D, James NH, et al. Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res, 2010, 16(14): 3548-3561.

引证文献15

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部